Thirdly, heterogeneous expression of immune checkpoint molecules contributes: pro-tumor subsets (Bregs, exhausted B cells) upregulate PD-L1, CTLA-4, etc., to transmit inhibitory signals, whereas antitumor subsets retain low checkpoint expression to maintain functionality (131). The gene discussed is CD274; the disease is neoplasm.